Similar to TRIM23, the overexpression of TRIM24 which is synonymously known as transcription intermediary factor 1α (TIF1α), positively correlates with tumor size and shorter survival time of CRC patients as indicated by Kaplan–Meier survival analysis [59]. This evidence concerns the gene TRIM24 and neoplasm.